Chevron Corp tiene un precio objetivo de consenso de $171.96 basado en las calificaciones de 25 analistas. El máximo es $200, emitido por B of A Securities el octubre 30, 2023. El mínimo es $124, emitido por Redburn Atlantic el abril 23, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Morgan Stanley, Raymond James y Wells Fargo el noviembre 3, 2025, octubre 17, 2025 y octubre 17, 2025, respectivamente. Con un precio objetivo promedio de $175.67 entre Morgan Stanley, Raymond James y Wells Fargo, hay una 13.26% upside implícita para Chevron Corp según estas calificaciones más recientes de analistas.
1calculado a partir de las calificaciones de los analistas
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/03/2025 | 14.12% | Morgan Stanley | $174 → $177 | Maintains | Overweight | |||
10/17/2025 | 3.16% | Raymond James | $170 → $160 | Reiterates | Outperform → Outperform | |||
10/17/2025 | 22.5% | Wells Fargo | → $190 | Initiates | → Overweight | |||
10/09/2025 | 6.38% | Scotiabank | $160 → $165 | Maintains | Sector Perform | |||
10/07/2025 | 1.87% | Barclays | $160 → $158 | Maintains | Equal-Weight | |||
09/15/2025 | 23.15% | Mizuho | $192 → $191 | Maintains | Outperform | |||
09/10/2025 | 19.28% | B of A Securities | $170 → $185 | Maintains | Buy | |||
08/20/2025 | 27.01% | UBS | $186 → $197 | Maintains | Buy | |||
08/20/2025 | -0.06% | Melius Research | → $155 | Initiates | → Hold | |||
08/18/2025 | 8.32% | Piper Sandler | $164 → $168 | Maintains | Overweight | |||
08/13/2025 | 23.79% | Mizuho | $186 → $192 | Maintains | Outperform | |||
08/04/2025 | 19.92% | UBS | $177 → $186 | Maintains | Buy | |||
07/31/2025 | 16.05% | Evercore ISI Group | → $180 | Reinstates | → Outperform | |||
07/23/2025 | 14.76% | Wells Fargo | $165 → $178 | Maintains | Overweight | |||
07/11/2025 | 3.16% | Scotiabank | $143 → $160 | Maintains | Sector Perform | |||
07/07/2025 | 0.58% | Barclays | $152 → $156 | Maintains | Equal-Weight | |||
07/02/2025 | 5.74% | Piper Sandler | $162 → $164 | Maintains | Overweight | |||
06/26/2025 | 6.38% | Wells Fargo | $164 → $165 | Maintains | Overweight | |||
05/13/2025 | 4.45% | Piper Sandler | $173 → $162 | Maintains | Overweight | |||
05/13/2025 | 1.87% | HSBC | $176 → $158 | Downgrade | Buy → Hold | |||
05/13/2025 | 19.92% | Mizuho | $188 → $186 | Maintains | Outperform | |||
05/05/2025 | 5.74% | Wells Fargo | $173 → $164 | Maintains | Overweight | |||
04/23/2025 | -20.05% | Redburn Atlantic | $156 → $124 | Downgrade | Neutral → Sell | |||
04/23/2025 | -2% | Barclays | $171 → $152 | Downgrade | Overweight → Equal-Weight | |||
04/15/2025 | 21.21% | Mizuho | $203 → $188 | Maintains | Outperform | |||
04/15/2025 | 11.54% | Wells Fargo | $184 → $173 | Maintains | Overweight | |||
04/11/2025 | -7.8% | Scotiabank | $160 → $143 | Downgrade | Sector Outperform → Sector Perform | |||
04/07/2025 | 19.28% | UBS | $194 → $185 | Maintains | Buy | |||
02/05/2025 | 30.88% | Mizuho | $194 → $203 | Maintains | Outperform | |||
02/05/2025 | 10.25% | Barclays | $174 → $171 | Maintains | Overweight | |||
02/04/2025 | 3.16% | Truist Securities | $164 → $160 | Maintains | Hold | |||
02/03/2025 | 25.08% | UBS | $195 → $194 | Maintains | Buy | |||
02/03/2025 | 12.83% | RBC Capital | $175 → $175 | Reiterates | Outperform → Outperform | |||
02/03/2025 | 18.63% | Wells Fargo | $188 → $184 | Maintains | Overweight | |||
02/03/2025 | 12.83% | Raymond James | $180 → $175 | Maintains | Outperform | |||
01/17/2025 | 16.05% | Raymond James | $175 → $180 | Maintains | Outperform | |||
01/13/2025 | 5.74% | Truist Securities | $160 → $164 | Maintains | Hold | |||
12/19/2024 | 11.54% | Piper Sandler | $184 → $173 | Maintains | Overweight | |||
12/09/2024 | 21.21% | Wells Fargo | $171 → $188 | Maintains | Overweight | |||
12/06/2024 | 3.16% | Truist Securities | $155 → $160 | Maintains | Hold | |||
12/03/2024 | 25.73% | UBS | $194 → $195 | Maintains | Buy | |||
11/26/2024 | 19.28% | Citigroup | $145 → $185 | Upgrade | Neutral → Buy | |||
11/07/2024 | 25.08% | Mizuho | $189 → $194 | Maintains | Outperform | |||
11/04/2024 | 25.08% | UBS | $192 → $194 | Maintains | Buy | |||
11/04/2024 | 12.83% | RBC Capital | $170 → $175 | Maintains | Outperform | |||
11/04/2024 | -0.06% | Truist Securities | $150 → $155 | Maintains | Hold | |||
11/04/2024 | 12.19% | Barclays | $168 → $174 | Maintains | Overweight | |||
10/17/2024 | 8.32% | B of A Securities | → $168 | Reinstates | → Buy | |||
10/10/2024 | 5.09% | Scotiabank | $180 → $163 | Maintains | Sector Outperform | |||
10/08/2024 | 23.79% | UBS | $189 → $192 | Maintains | Buy | |||
10/08/2024 | 9.61% | RBC Capital | $170 → $170 | Reiterates | Outperform → Outperform | |||
10/03/2024 | 8.32% | Barclays | $185 → $168 | Maintains | Overweight | |||
09/30/2024 | -3.29% | Truist Securities | $154 → $150 | Maintains | Hold | |||
09/27/2024 | 8.96% | Wells Fargo | $196 → $169 | Maintains | Overweight | |||
09/18/2024 | 21.86% | UBS | $192 → $189 | Maintains | Buy | |||
09/16/2024 | 21.86% | Mizuho | $205 → $189 | Maintains | Outperform | |||
08/06/2024 | 19.28% | Barclays | $203 → $185 | Maintains | Overweight | |||
08/05/2024 | 16.05% | RBC Capital | $190 → $180 | Maintains | Outperform | |||
08/05/2024 | -0.71% | Truist Securities | $156 → $154 | Maintains | Hold | |||
07/22/2024 | 0.58% | Truist Securities | $166 → $156 | Maintains | Hold | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/17/2024 | 7.67% | Bernstein | $183 → $167 | Downgrade | Outperform → Market Perform | |||
07/12/2024 | 16.05% | Scotiabank | $195 → $180 | Maintains | Sector Outperform | |||
05/13/2024 | 32.17% | Mizuho | $200 → $205 | Maintains | Buy | |||
05/10/2024 | 7.03% | Truist Securities | $156 → $166 | Maintains | Hold | |||
04/30/2024 | 14.76% | HSBC | $175 → $178 | Maintains | Buy | |||
04/30/2024 | 32.82% | Wells Fargo | $198 → $206 | Maintains | Overweight | |||
04/29/2024 | 3.16% | TD Cowen | $155 → $160 | Maintains | Hold | |||
04/18/2024 | 31.53% | Piper Sandler | $180 → $204 | Maintains | Overweight | |||
04/15/2024 | 12.19% | Raymond James | $170 → $174 | Maintains | Outperform | |||
04/11/2024 | 25.73% | Scotiabank | $170 → $195 | Upgrade | Sector Perform → Sector Outperform | |||
04/10/2024 | 30.88% | Barclays | → $203 | Initiates | → Overweight | |||
04/09/2024 | 27.01% | UBS | $185 → $197 | Maintains | Buy | |||
04/05/2024 | 0.58% | Truist Securities | $168 → $156 | Maintains | Hold | |||
04/04/2024 | 27.66% | Wells Fargo | $185 → $198 | Maintains | Overweight | |||
04/01/2024 | — | Goldman Sachs | — | Maintains | Buy | |||
03/20/2024 | 28.95% | Mizuho | $195 → $200 | Maintains | Buy | |||
03/14/2024 | 16.05% | Piper Sandler | $188 → $180 | Maintains | Overweight | |||
02/06/2024 | 3.16% | DZ Bank | → $160 | Downgrade | Buy → Hold | |||
02/05/2024 | 22.5% | RBC Capital | $185 → $190 | Maintains | Outperform | |||
01/23/2024 | -3.29% | TD Cowen | $170 → $150 | Downgrade | Outperform → Market Perform | |||
01/16/2024 | 9.61% | Scotiabank | → $170 | Downgrade | Sector Outperform → Sector Perform | |||
01/08/2024 | 18.63% | Jefferies | → $184 | Upgrade | Hold → Buy | |||
12/14/2023 | 19.28% | UBS | $194 → $185 | Maintains | Buy | |||
11/14/2023 | 25.73% | Mizuho | $215 → $195 | Maintains | Buy | |||
11/02/2023 | 17.34% | Bernstein | $184 → $182 | Upgrade | Market Perform → Outperform | |||
10/30/2023 | 28.95% | B of A Securities | $190 → $200 | Upgrade | Neutral → Buy | |||
10/30/2023 | 12.83% | Raymond James | $200 → $175 | Maintains | Outperform | |||
10/24/2023 | 8.96% | Truist Securities | $175 → $169 | Maintains | Hold | |||
10/24/2023 | 16.05% | RBC Capital | → $180 | Reiterates | Outperform → Outperform | |||
10/17/2023 | 29.59% | Morgan Stanley | $203 → $201 | Maintains | Equal-Weight | |||
10/17/2023 | 18.63% | Bernstein | → $184 | Initiates | → Market Perform | |||
10/04/2023 | 35.4% | UBS | $209 → $210 | Maintains | Buy | |||
10/02/2023 | 30.88% | Morgan Stanley | $198 → $203 | Maintains | Equal-Weight | |||
09/18/2023 | 38.62% | Mizuho | $209 → $215 | Maintains | Buy | |||
08/18/2023 | 27.66% | Morgan Stanley | $197 → $198 | Maintains | Equal-Weight | |||
08/17/2023 | 34.75% | UBS | $202 → $209 | Maintains | Buy | |||
08/16/2023 | — | Mizuho | — | Upgrade | Neutral → Buy | |||
08/01/2023 | 20.57% | Goldman Sachs | $166 → $187 | Maintains | Buy | |||
07/31/2023 | 6.38% | Truist Securities | $163 → $165 | Maintains | Hold |
El último precio objetivo de Chevron (NYSE:CVX) fue comunicado por Morgan Stanley el noviembre 3, 2025. La firma de analistas fijó un precio objetivo para $177.00 que espera CVX a rise dentro de 12 meses (un posible 14.12% upside). 42 firmas de analistas han reportado calificaciones en el último año.
La última calificación de analistas para Chevron (NYSE:CVX) fue proporcionada por Morgan Stanley, y Chevron mantuvo su overweight calificación.
La última revisión al alza de Chevron Corp se produjo en noviembre 26, 2024, cuando Citigroup elevó su precio objetivo a $185. Citigroup anteriormente tenía a neutral para Chevron Corp.
La última revisión a la baja de Chevron Corp se produjo en mayo 13, 2025, cuando HSBC cambió su precio objetivo de $176 a $158 para Chevron Corp.
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de Chevron, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de Chevron se registró el noviembre 3, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 3, 2026.
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de Chevron (CVX) fue un mantuvo con un precio objetivo de $174.00 a $177.00. El precio actual al que cotiza Chevron (CVX) es de $155.10, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.